Navigation Links
Fall Zeltiq - CLINIPRO: Gericht entscheidet LipoCryo-Klage zugunsten von Clinipro
Date:1/30/2013

BARCELONA, Spanien, January 30, 2013 /PRNewswire/ --

CLINIPRO, ein spanischer Hersteller von medizinisch-ästhetischen Geräten, gibt bekannt, dass das Handelsgericht Nr. 5 Barcelona einen Beschluss angeordnet hat, der auf den 25. Januar 2013 datiert ist und der die von Zeltiq Aesthetics Inc. (Nasdaq: ZLTQ) und dem Massachusetts General Hospital (MGH) angestrengte Klage gegen CLINIPRO wegen angeblicher Patentverletzungen und illoyaler Kompetenzhandlungen vollständig abgewiesen wird. Der Fall wurde von der Kanzlei SOL MUNTAÑOLA & ASOCIADOS übernommen, die von CLINIPRO zur Abwicklung der Rechtsangelegenheit beauftragt worden war.

Das Urteil besagt, die Patente der Kläger werdenaufgrund des Mangels an erfinderischer Tätigkeit (das Verfahrenspatent) und des Mangels an Neuerungen (das Gerätepatent) aufgehoben, weshalb die eingereichte Klage abgewiesen werde. Darüber hinaus weist das Urteil die Existenz von illoyalem Verhalten, die ebenfalls Teil der Klage war, unter anderem deshalb ab, weil Zeltiq und das MGH sich nicht den Name der Technik zu eigen machen können, die das Kälteverfahren zur Fettreduzierung beschreibt (Cryolipolyse). Gemäß dem Urteil müssen Zeltiq und das MGH die entstandenen Kosten tragen, wobei CLINIPRO die Möglichkeit in Betracht zieht, auf Schaden- und Aufwendungsersatz zu klagen.

Es muss daran erinnert werden, dass aufgrund der von dem MGH und von Zeltiq eingereichten Klage gegen CLINIPRO wegen Urheberrechtsverletzungen am 5. Mai 2012 ein vorläufiger Beschluss angeordnet worden war, in dem Vorsichtsmaßnahmen gegen die Vermarktung von LipoCryo in Spanien festgelegt wurden. Später wurde dieser Beschluss in einem Urteil vom 25. Juni 2012 für nichtig erklärt, wobei sich das Gericht mit der Hinterlegung einer substitutiven Kaution einverstanden er
'/>"/>

SOURCE Clinipro S.L
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Case Zeltiq - CLINIPRO: The Court Upholds Clinipro - LipoCryo Claim
2. Caso Zeltiq - CLINIPRO: El juzgado da la razón a CLINIPRO - LipoCryo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... ... Ralco is honored to announce that it is the primary sponsor of the ... in Marshall. The Ralco Enrichment Center is an interactive experience where the public can ... lives. This unique exhibit also features a birthing center for fair goers to watch ...
(Date:7/30/2015)... July 30, 2015   GenoSpace , a ... interpretation and analysis of genomic and other biomedical ... has joined the company as Vice President of ... http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace partners with ... interpret, analyze and explore complex sets of genomic, ...
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research Report on ... current state of the global Propanol market with a focus on the Chinese situation. ... Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang ...
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative veterinary medicine company, ... canine osteoarthritis stem cell product, currently under development for FDA approval. The product ... marketed in the US by Aratana. This product, termed AT-016, is an allogeneic ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3
... (Nasdaq: NPSP ) announced today that it ... decision whether to,proceed with ex-U.S. development and commercialization ... expects to receive,notification from Nycomed at the end ... NPS on the development of GATTEX(TM) (teduglutide),outside North ...
... presented at AACR-NCI-EORTC International Conference on ... and Cancer Therapeutics in San Francisco, ... Zentaris Inc.,(TSX: AEZ; Nasdaq: AEZS), a global ... today presented an abstract outlining novel,data generated ...
... antibody uses novel approach to "de-cloak" cancers -, ... Inc., (TSX:,ARI), a biotechnology company discovering and developing ... new findings have been,presented from its Trop-2 and ... Trop-2 and CD59 abstracts at the AACR press,conference ...
Cached Biology Technology:NPS Pharmaceuticals to Report Third Quarter 2007 Financial Results and Nycomed Decision on GATTEX(TM) Partnership on November 1, 2007 2AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment 2AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment 3AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment 4Arius announces new findings in Trop-2 and CD59 CANCER antibody programs 2Arius announces new findings in Trop-2 and CD59 CANCER antibody programs 3
(Date:7/30/2015)... , July 30, 2015 Cellecta, ... for gene function analysis and biomarker discovery, announced ... (sgRNA) Knockout Library targeting all human protein coding ... permanently "knock out" a gene,s function. Cellecta,s new ... high throughput screening tool so that researchers can ...
(Date:7/23/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ... "Global Outlook of the Biometrics Industry 2015 " ... The global biometrics market is likely to witness ... owing to the uptake of multiple technologies available. ... enhances the growth of biometrics in existing applications ...
(Date:7/20/2015)... 2015  Acuity Market Intelligence,s latest research "The ... Commerce and Privacy" forecasts that between 2014 and ... be downloaded to smart mobile devices by 2.2 ... is projected to generate more than $67.9 billion ... forecast period.    "Biometrics is at ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... 19, 2009Researchers at The Scripps Research Institute, the University ... used a very sensitive fluorescence technique to find that ... three-dimensional structure (shape), can actually twist itself into a ... folded form is active and the other is inactive, ...
... still be hunters and gatherers, and modern civilization would ... who do not relish the thought of spending our ... cultivated many species of animals and plants found in ... various species provide a fascinating glimpse into the past. ...
... EAST LANSING, Mich. Michigan State University has ... serve as the data coordinating center for the largest ... Informatics Core, established in 2001 and now part of ... and create a repository for data from nearly 3,000 ...
Cached Biology News:Researchers observe single protein dimers wavering between two symmetrically opposed structures 2Researchers observe single protein dimers wavering between two symmetrically opposed structures 3Researchers observe single protein dimers wavering between two symmetrically opposed structures 4Domestication of Capsicum annuum chile pepper provides insights into crop origin and evolution 2MSU lands $2.1 million grant to take part in national autism study 2
... (human), clone 41D GenBank Accession ... Native clusterin purified from human serum ... NaCl and 0.05% sodium azide Quality ... from HeLa cells or MCF-7 cell ...
Component in MasterPure™ Purification Kits...
Mouse monoclonal [TU-20] to beta III Tubulin (FITC) ( Abpromise for all tested applications). entrezGeneID: 10381 SwissProtID: Q13509...
Phospho-FKHR (Thr24)/FKHRL1 (Thr32) Antibody...
Biology Products: